Adipokine profile in celiac patients: differences in comparison with patients suffering from diarrhea-predominant IBS and healthy subjects

References

• Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 2012;18:6036–59.
   PubMed Web of Science ®Google Scholar
• Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004;21:357–66.
   PubMed Web of Science ®Google Scholar
• Manavalan JS, Hernandez L, Shah JG, Konikkara J, Naiyer AJ, Lee AR, et al. Serum cytokine elevations in celiac disease: association with disease presentation. Hum Immunol 2010;71:50–7.
   PubMed Web of Science ®Google Scholar
• Ferretti G, Bacchetti T, Masciangelo S, Saturni L. Celiac disease, inflammation and oxidative damage: a nutrigenetic approach. Nutrients 2012;4:243–57.
   PubMed Web of Science ®Google Scholar
• Shahbazkhani B, Forootan M, Merat S, Akbari MR, Nasserimoghadam S, Vahedi H, et al. Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2003;18:231–5.
   PubMed Web of Science ®Google Scholar
• Chang L, Lacy BE, Spiegel BMR. An evidence-based approach to therapy in IBS-D: a case study compendium. Gastroenterol Hepatol (N Y) 2010;6:1–12.
   PubMedGoogle Scholar
• Haines ML, Anderson RP, Gibson PR. Systematic review: the evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther 2008;28:1042–66.
   PubMed Web of Science ®Google Scholar
• Scully P, McKernan DP, Keohane J, Groeger D, Shanahan F, Dinan TG, et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 2010;105:2235–43.
   PubMed Web of Science ®Google Scholar
• Gwee KA, Collins SM, Read NW, Rajnakova A, Deng Y, Graham JC, et al. Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious irritable bowel syndrome. Gut 2003;52:523–6.
   PubMed Web of Science ®Google Scholar
• Feng B, La JH, Schwartz ES, Gebhart GF. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012;302:G1085–98.
   PubMed Web of Science ®Google Scholar
• Valentini L, Wirth EK, Schweizer U, Hengstermann S, Schaper L, Koernicke T, et al. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition 2009;25:172–81.
   PubMed Web of Science ®Google Scholar
• Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:100–5.
   PubMed Web of Science ®Google Scholar
• Jamaluddin MS, Weakley SM, Yao Q, Chen C. Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol 2012;165:622–32.
   PubMed Web of Science ®Google Scholar
• Menzaghi C, Coco A, Salvemini L, Thompson R, De Cosmo S, Doria A, et al. Heritability of serum resistin and its genetic correlation with insulin resistance-related features in non-diabetic Caucasians. J Clin Endocrinol Metab 2006;91:2792–5.
   PubMed Web of Science ®Google Scholar
• Otero M, Lago R, Gomez R, Dieguez C, Lago F, Gomez-Reino J, et al. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 2006;45:944–50.
   PubMed Web of Science ®Google Scholar
• Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne) 2013;12:4; 71.
   Google Scholar
• Lago F, Dieguez C, Gómez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007;18:313–25.
   PubMed Web of Science ®Google Scholar
• Rigsbee L, Agans R, Shankar V, Kenche H, Khamis HJ, Michail S, et al. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2012;107:1740–51.
   PubMed Web of Science ®Google Scholar
• Schmulson M, Lee OY, Chang L, Naliboff B, Mayer EA. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol 1999;94:2929–35.
   PubMed Web of Science ®Google Scholar
• Antonioli DA. Celiac disease: a progress report. Mod Pathol 2003;16:342–6.
   PubMed Web of Science ®Google Scholar
• Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480–91.
   PubMed Web of Science ®Google Scholar
• Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol 2009;104:1587–94.
   PubMed Web of Science ®Google Scholar
• Kunnari A, Ukkola O, Kesaniemi YA. Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients. Diabet Med 2005;22:583–9.
   PubMed Web of Science ®Google Scholar
• Mearin F, Balboa A, Badía X, Baró E, Caldwell E, Cucala M, et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003;15:165–72.
   PubMed Web of Science ®Google Scholar
• Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010;7:163–73.
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003;46:1594–603.
   PubMed Web of Science ®Google Scholar
• Fornari MC, Pedreira S, Niveloni S, González D, Diez RA, Vázquez H, et al. Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol 1998;93:413–18.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Pacheco F, Novelle MG, Vazquez MJ, Garcia-Escobar E, Soriguer F, Rojo-Martinez G, et al. Resistin regulates pituitary lipid metabolism and inflammation in vivo and in vitro. Mediators Inflamm 2013;2013:479739.
   PubMed Web of Science ®Google Scholar
• Filková M, Haluzík M, Gay S, Senolt L. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol 2009;133:157–70.
   PubMed Web of Science ®Google Scholar
• Suriyaprom K, Phonrat B, Namjuntra P, Chanchay S, Tungtrongchitr R. The +299(G > A) resistin gene polymorphism and susceptibility to type 2 diabetes in Thais. J Clin Biochem Nutr 2009;44:104–10.
   PubMed Web of Science ®Google Scholar
• Ballinger A, Kelly P, Hallyburton E, Besser R, Farthing M. Plasma leptin in chronic inflammatory bowel disease and HIV: implications for the pathogenesis of anorexia and weight loss. Clin Sci 1998;94:479–83.
   PubMed Web of Science ®Google Scholar
• Blanco Quiros A, Arranz Sanza E, Garrote Adrados JA, Oyágüez Ugidos P, Calvo Romero C, Alonso Franch M. The tumor necrosis factor system and leptin in coeliac disease. An Esp Pediatr 2001;55:198–204.
   PubMedGoogle Scholar
• Ertekin V, Orbak Z, Selimoglu MA, Yildiz L. Serum leptin levels in childhood celiac disease. J Clin Gastroenterol 2006;40:906–9.
   PubMed Web of Science ®Google Scholar
• Capristo E, Farnetti S, Mingrone G, Certo M, Greco AV, Addolorato G, et al. Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatment. Scand J Gastroenterol 2005;40:430–6.
   PubMed Web of Science ®Google Scholar
• Maggio MC, Corsello G, Iacono G, Teresi S, Guicciardino E, Terrana S, et al. Gluten-free diet impact on leptin levels in asymptomatic coeliac adolescents: one year of follow-up. Horm Res 2007;67:100–4.
   PubMedGoogle Scholar
• Semnani S, Roshandel G, Keshtkar A, Najafi L, Amiriani T, Farajollahi M, et al. Serum leptin levels and irritable bowel syndrome: a new hypothesis. J Clin Gastroenterol 2009;43:826–30.
   PubMed Web of Science ®Google Scholar
• Liu M, Liu F. Transcriptional and post-translational regulation of adiponectin. Biochem J 2009;425:41–52.
   PubMed Web of Science ®Google Scholar
• Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, Butler MG. Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Int J Obes (Lond) 2006;30:382–7.
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adiponectin and inflammation: Consensus and controversy. J Allergy Clin Immunol 2008;121:326–30.
   PubMed Web of Science ®Google Scholar